References
- Kanwar AJ, Dhar S, Kaur S. Treatment of melasma with potent topical corticosteroids. Dermatology. 1994;188:170.
- Westerhof W, Kooyers TJ. Hydroquinone and its analogues in dermatology - a potential health risk. J Cosmet Dermatol. 2005;4:55–59.
- Nordlund JJ, Grimes PE, Ortonne JP. The safety of hydroquinone. J Eur Acad Dermatol Venereol. 2006;20:781–787.
- Goldberg DJ. Laser treatment of pigmented lesions. Dermatol Clin. 1997;15:397–406.
- Stratigos AJ, Dover JS, Arndt KA. Laser treatment of pigmented lesions – 2000. How far have we gone? Arch Dermatol. 2000;136: 915–921.
- Glaich AS, Goldberg LH, Dai T, Kunishige JH, Friedman PM. Fractional resurfacing: A new therapeutic modality for Becker's nevus. Arch Dermatol. 2007;143:1488–1490.
- Kouba DJ, Fincher EF, Moy RL. Nevus of Ota successfully treated by fractional photothermolysis using a fractionated 1440-nm Nd:YAG laser. Arch Dermatol. 2008;144:156–158.
- Katz TM, Goldberg LH, Firoz BF, Friedman PM. Fractional photothermolysis in the treatment of postinflammatory hyperpigmentation. Dermatol Surg. 2009;35:1844–1848.
- Rokhsar CK, Ciocon DH. Fractional photothermolysis for the treatment of postinflammatory hyperpigmentation after carbon dioxide laser resurfacing. Dermatol Surg. 2009;35:535–537.
- Rokhsar CK, Fitzpatrick RE. The treatment of melasma with fractional photothermolysis: A pilot study. Dermatol Surg. 2005;31:1645–1650.
- Katz TM, Glaich AS, Goldberg LH, Firoz BF, Dai T, Friedman PM. Treatment of melasma using fractional photothermolysis: A report of eight cases with long-term follow-up. Dermatol Surg. 2010;36: 1273–1280.
- Anderson RR, Parrish JA. Selective photothermolysis. Precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220:524–527.
- Lee MW. Combination 532-nm and 1064-nm lasers for noninvasive skin rejuvenation and toning. Arch Dermatol. 2003;139:1265–76.
- Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. J Dermatol Sci. 2007;46:111–116.
- Schmults CD, Phelps R, Goldberg DJ. Nonablative facial remodeling, erythema reduction and histologic evidence of new collagen formation using a 300-microsecond 1064-nm Nd:YAG laser. Arch Dermatol. 2004;140:1373–1376.
- Manaloto RMP, Alster TS. Erbium:YAG laser resurfacing for refractory melasma. Dermatol Surg. 1999;25:121–123.
- Angsuwarangsee S, Polnikorn N. Combined ultrapulse CO2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma: Split face design. Dermatol Surg. 2003;29:59–64.